Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese Children

Background: Intranasal application is a comfortable, effective, nearly non-invasive, and easy route of administration in children. To date, there is, however, only one pharmacokinetic study on intranasal dexmedetomidine in pediatric populations and none in Chinese children available. Therefore, this...

Full description

Bibliographic Details
Main Authors: Cheng-Yu Wang, Harald Ihmsen, Zhi-Yan Hu, Jia Chen, Xue-Fei Ye, Fang Chen, Yi Lu, Jürgen Schüttler, Qing-Quan Lian, Hua-Cheng Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-07-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00756/full
id doaj-d8ab18ca9f2840d281fcae6f2bb2c113
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Cheng-Yu Wang
Cheng-Yu Wang
Harald Ihmsen
Zhi-Yan Hu
Zhi-Yan Hu
Jia Chen
Jia Chen
Xue-Fei Ye
Xue-Fei Ye
Fang Chen
Fang Chen
Yi Lu
Yi Lu
Jürgen Schüttler
Qing-Quan Lian
Qing-Quan Lian
Hua-Cheng Liu
Hua-Cheng Liu
spellingShingle Cheng-Yu Wang
Cheng-Yu Wang
Harald Ihmsen
Zhi-Yan Hu
Zhi-Yan Hu
Jia Chen
Jia Chen
Xue-Fei Ye
Xue-Fei Ye
Fang Chen
Fang Chen
Yi Lu
Yi Lu
Jürgen Schüttler
Qing-Quan Lian
Qing-Quan Lian
Hua-Cheng Liu
Hua-Cheng Liu
Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese Children
Frontiers in Pharmacology
dexmedetomidine
intranasal
pharmacokinetics
pediatrics
Chinese
author_facet Cheng-Yu Wang
Cheng-Yu Wang
Harald Ihmsen
Zhi-Yan Hu
Zhi-Yan Hu
Jia Chen
Jia Chen
Xue-Fei Ye
Xue-Fei Ye
Fang Chen
Fang Chen
Yi Lu
Yi Lu
Jürgen Schüttler
Qing-Quan Lian
Qing-Quan Lian
Hua-Cheng Liu
Hua-Cheng Liu
author_sort Cheng-Yu Wang
title Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese Children
title_short Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese Children
title_full Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese Children
title_fullStr Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese Children
title_full_unstemmed Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese Children
title_sort pharmacokinetics of intranasally administered dexmedetomidine in chinese children
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2019-07-01
description Background: Intranasal application is a comfortable, effective, nearly non-invasive, and easy route of administration in children. To date, there is, however, only one pharmacokinetic study on intranasal dexmedetomidine in pediatric populations and none in Chinese children available. Therefore, this study aimed to characterize the pharmacokinetics of intranasally administered dexmedetomidine in Chinese children.Methods: Thirteen children aged 4 to 10 years undergoing surgery received 1 µg/kg dexmedetomidine intranasally. Arterial blood samples were drawn at various time points until 180 min after dose. Dexmedetomidine plasma concentrations were measured with high performance liquid chromatography (HPLC) and mass spectrometry. Pharmacokinetic modeling was performed by population analysis using linear compartment models with first-order absorption.Results: An average peak plasma concentration of 748 ± 30 pg/ml was achieved after 49.6 ± 7.2 min. The pharmacokinetics of dexmedetomidine was best described by a two-compartment model with first-order absorption and an allometric scaling with estimates standardized to 70-kg body weight. The population estimates (SE) per 70 kg bodyweight of the apparent pharmacokinetic parameters were clearance CL/F = 0.32 (0.02) L/min, central volume of distribution V1/F = 34.2 (4.9) L, intercompartmental clearance Q2/F = 10.0 (2.2) L/min, and peripheral volume of distribution V2/F = 34.9 (2.3) L. The estimated absorption rate constant was Ka = 0.038 (0.004) min−1.Conclusions: When compared with studies in Caucasians, Chinese children showed a similar time to peak plasma concentration after intranasal administration, but the achieved plasma concentrations were about three times higher. Possible reasons are differences in age, ethnicity, and mode of administration.
topic dexmedetomidine
intranasal
pharmacokinetics
pediatrics
Chinese
url https://www.frontiersin.org/article/10.3389/fphar.2019.00756/full
work_keys_str_mv AT chengyuwang pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren
AT chengyuwang pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren
AT haraldihmsen pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren
AT zhiyanhu pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren
AT zhiyanhu pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren
AT jiachen pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren
AT jiachen pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren
AT xuefeiye pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren
AT xuefeiye pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren
AT fangchen pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren
AT fangchen pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren
AT yilu pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren
AT yilu pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren
AT jurgenschuttler pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren
AT qingquanlian pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren
AT qingquanlian pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren
AT huachengliu pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren
AT huachengliu pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren
_version_ 1725383299987144704
spelling doaj-d8ab18ca9f2840d281fcae6f2bb2c1132020-11-25T00:16:19ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122019-07-011010.3389/fphar.2019.00756464117Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese ChildrenCheng-Yu Wang0Cheng-Yu Wang1Harald Ihmsen2Zhi-Yan Hu3Zhi-Yan Hu4Jia Chen5Jia Chen6Xue-Fei Ye7Xue-Fei Ye8Fang Chen9Fang Chen10Yi Lu11Yi Lu12Jürgen Schüttler13Qing-Quan Lian14Qing-Quan Lian15Hua-Cheng Liu16Hua-Cheng Liu17Department of Anesthesiology, Perioperative and Pain Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaKey Laboratory of Anesthesiology of Zhejiang Province, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaDepartment of Anesthesiology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, GermanyDepartment of Anesthesiology, Perioperative and Pain Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaKey Laboratory of Anesthesiology of Zhejiang Province, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaDepartment of Anesthesiology, Perioperative and Pain Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaKey Laboratory of Anesthesiology of Zhejiang Province, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaDepartment of Anesthesiology, Perioperative and Pain Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaKey Laboratory of Anesthesiology of Zhejiang Province, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaDepartment of Anesthesiology, Perioperative and Pain Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaKey Laboratory of Anesthesiology of Zhejiang Province, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaDepartment of Anesthesiology, Perioperative and Pain Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaKey Laboratory of Anesthesiology of Zhejiang Province, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaDepartment of Anesthesiology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, GermanyDepartment of Anesthesiology, Perioperative and Pain Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaKey Laboratory of Anesthesiology of Zhejiang Province, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaDepartment of Anesthesiology, Perioperative and Pain Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaKey Laboratory of Anesthesiology of Zhejiang Province, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaBackground: Intranasal application is a comfortable, effective, nearly non-invasive, and easy route of administration in children. To date, there is, however, only one pharmacokinetic study on intranasal dexmedetomidine in pediatric populations and none in Chinese children available. Therefore, this study aimed to characterize the pharmacokinetics of intranasally administered dexmedetomidine in Chinese children.Methods: Thirteen children aged 4 to 10 years undergoing surgery received 1 µg/kg dexmedetomidine intranasally. Arterial blood samples were drawn at various time points until 180 min after dose. Dexmedetomidine plasma concentrations were measured with high performance liquid chromatography (HPLC) and mass spectrometry. Pharmacokinetic modeling was performed by population analysis using linear compartment models with first-order absorption.Results: An average peak plasma concentration of 748 ± 30 pg/ml was achieved after 49.6 ± 7.2 min. The pharmacokinetics of dexmedetomidine was best described by a two-compartment model with first-order absorption and an allometric scaling with estimates standardized to 70-kg body weight. The population estimates (SE) per 70 kg bodyweight of the apparent pharmacokinetic parameters were clearance CL/F = 0.32 (0.02) L/min, central volume of distribution V1/F = 34.2 (4.9) L, intercompartmental clearance Q2/F = 10.0 (2.2) L/min, and peripheral volume of distribution V2/F = 34.9 (2.3) L. The estimated absorption rate constant was Ka = 0.038 (0.004) min−1.Conclusions: When compared with studies in Caucasians, Chinese children showed a similar time to peak plasma concentration after intranasal administration, but the achieved plasma concentrations were about three times higher. Possible reasons are differences in age, ethnicity, and mode of administration.https://www.frontiersin.org/article/10.3389/fphar.2019.00756/fulldexmedetomidineintranasalpharmacokineticspediatricsChinese